We’re one step closer to a cancer vaccine
The Moderna/Merck duo has a breakthrough for melanoma patients
Stay ahead of the curve on vaccines & infectious disease research with our expert reporting on the people, companies, and trends defining the industry.
The Moderna/Merck duo has a breakthrough for melanoma patients
The vaccine works like immunotherapy.
Nineteen other African countries are planning to start immunization programs this year.
Their research in mRNA vaccine technology could lead to vaccines for diseases like HIV, malaria, and the flu.
We took a look at the discussion around biosafety in research labs as a congressional subcommittee attempts interrogate the lab leak theory.
The lawsuit seeks damages for most vaccines sold since early March of this year.
The Omicron-specific vaccine is being tested both as a three-shot series and a booster.
Morning Brew delivers quick and insightful updates about the business world every day of the week from Wall St. to Silicon Valley.
By subscribing, you accept our Terms & Privacy Policy.